Tafamidis

Tafamidis
Product Description

Process validation will be completed in early 2025.

Read more Show less

Shiratori Pharmaceutical

  • Country/Region:
    Japan
  • On CPHI since:
    2020
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Process patent to reduce the impurities has been filed in Japan.
  • Supplied from
    Japan
  • Measured In
    gram
More specifications Fewer specifications
Sales Markets
Show more Show less

Shiratori Pharmaceutical

  • Country/Region:
    Japan
  • On CPHI since:
    2020
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer
View company profile

More Products from Shiratori Pharmaceutical (4)

  • Bortezomib

    Product Bortezomib

    Manufacturing technology can be transfered.
  • Brexpiprazole

    Product Brexpiprazole

    To be supplied to USA, EU and Japan.
  • Eltrombopag Olamine

    Product Eltrombopag Olamine

    Process validation is to be carried out soon.
  • Pemafibrate

    Product Pemafibrate

    To be supplied to USA, EU and Japan.